Related Experiment Videos
Targeting to lymphoid cells of the immune network
Pharmacology & Therapeutics
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Responses of cloned rainbow trout Oncorhynchus mykiss to an attenuated strain of infectious hematopoietic necrosis virus.
Diseases of aquatic organisms·2000
Cloning, mapping and genomic organization of a fish C-type lectin gene from homozygous clones of rainbow trout (Oncorhynchus mykiss).
Biochimica et biophysica acta·2000
Cloning, characterization and genomic structure of the natural killer cell enhancement factor (NKEF)-like gene from homozygous clones of rainbow trout (Oncorhynchus mykiss).
Developmental and comparative immunology·2000
Immunogenicity of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells.
Diseases of aquatic organisms·1999
Temperature dependent characteristics of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells.
Diseases of aquatic organisms·1999
Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A.
Pharmacology & therapeutics·2026
Targeting metabolic reprogramming in cancer: Past, present, and future.
Pharmacology & therapeutics·2026
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.
Pharmacology & therapeutics·2026
Mechanisms of 'metabolizeaccretion' and therapeutic targets in influenza infection.
Pharmacology & therapeutics·2026
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research.
Pharmacology & therapeutics·2026
[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].
Therapeutische Umschau. Revue therapeutique·2026
[Immune-related adverse events of immune checkpoint inhibitors].
Therapeutische Umschau. Revue therapeutique·2026
Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.
Central-European journal of immunology·2026